{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:53:39Z","timestamp":1791327219982,"version":"4.3.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 219"],"award-info":[{"award-number":["TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Project-ID 322900939 (M03, M05)"],"award-info":[{"award-number":["Project-ID 322900939 (M03, M05)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1739 Project ID-546544928 (SD-07)"],"award-info":[{"award-number":["SFB 1739 Project ID-546544928 (SD-07)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejim.2026.107222","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:34:09Z","timestamp":1791200049000},"page":"107222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Innovative holistic treatment for CKM: what lies ahead?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-4804","authenticated-orcid":false,"given":"Paul","family":"Balfanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejim.2026.107222_bib0001","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1681\/ASN.0000000658","article-title":"Global burden of the key components of cardiovascular-kidney-metabolic syndrome","volume":"36","author":"Xie","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"10159","key":"10.1016\/j.ejim.2026.107222_bib0002","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.107222_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"issue":"10431","key":"10.1016\/j.ejim.2026.107222_bib0004","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejim.2026.107222_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-kidney-metabolic (CKM) syndrome: a state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"21","key":"10.1016\/j.ejim.2026.107222_bib0006","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"Jama"},{"issue":"20","key":"10.1016\/j.ejim.2026.107222_bib0007","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"48","key":"10.1016\/j.ejim.2026.107222_bib0009","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2026.107222_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.ejim.2026.107222_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001453","article-title":"2026 AHA\/ACC\/ADA\/ASN Guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"154","author":"Ndumele","year":"2026","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ejim.2026.107222_bib0014","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.125.077894","article-title":"Cardiovascular\u2013kidney\u2013metabolic syndrome stages, echocardiographic characteristics, and heart failure risk: the atherosclerosis risk in communities study","volume":"153","author":"Lassen","year":"2026","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ejim.2026.107222_bib0015","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ejim.2026.107222_bib0016","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J"},{"issue":"4S","key":"10.1016\/j.ejim.2026.107222_bib0017","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ejim.2026.107222_bib0018","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.ejim.2026.107222_bib0019","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.ejim.2026.107222_bib0020","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2026.107222_bib0021","first-page":"1645","article-title":"Adiponectin regulates albuminuria and podocyte function in mice","volume":"118","author":"Sharma","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2026.107222_bib0022","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejim.2026.107222_bib0023","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2026.107222_bib0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/db20211-13","article-title":"The interplay between diabetes, cardiovascular disease, and kidney disease","volume":"2021","author":"Usman","year":"2021","journal-title":"ADA Clin Compend"},{"key":"10.1016\/j.ejim.2026.107222_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-025-10013-6","article-title":"The evolving concept from cardiovascular-kidney-metabolic syndrome to metabolic associated liver-cardiovascular-kidney syndrome: insights from endocrinology","author":"Bian","year":"2026","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0026","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000539371","article-title":"Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes Facts"},{"issue":"9","key":"10.1016\/j.ejim.2026.107222_bib0027","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0028","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.ejim.2026.107222_bib0029","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1007\/s00330-024-10798-1","article-title":"Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis","volume":"34","author":"Edin","year":"2024","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ejim.2026.107222_bib0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/jdi.13430","article-title":"Association of the non-alcoholic fatty liver disease fibrosis score with subclinical myocardial remodeling in patients with type 2 diabetes: a cross-sectional study in China","volume":"12","author":"Fan","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"5","key":"10.1016\/j.ejim.2026.107222_bib0031","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11739-022-02966-2","article-title":"Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease","volume":"17","author":"Sonaglioni","year":"2022","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0032","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70084","article-title":"Cellular senescence, inflammaging and cardiovascular disease","volume":"337","author":"Zanders","year":"2026","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.ejim.2026.107222_bib0033","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.125.325637","article-title":"Aging at the crossroads of organ interactions: implications for the heart","volume":"136","author":"Sen","year":"2025","journal-title":"Circ Res"},{"issue":"14","key":"10.1016\/j.ejim.2026.107222_bib0034","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.107222_bib0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.echo.2014.01.001","article-title":"Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus","volume":"27","author":"Ernande","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2026.107222_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118269","article-title":"Animal models for preclinical research on multifactorial human conditions: the case of cardiovascular-kidney-metabolic syndrome","volume":"189","author":"Jasi\u0144ska-Stroschein","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejim.2026.107222_bib0037","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/DMSO.S408170","article-title":"Translation animal models of diabetic kidney disease: biochemical and histological phenotypes, advantages and limitations","volume":"Volume 16","author":"Luo","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"10.1016\/j.ejim.2026.107222_bib0038","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0039","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1152\/ajprenal.00204.2005","article-title":"Impact of genetic background on nephropathy in diabetic mice","volume":"290","author":"Gurley","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42670-5","article-title":"Both sexes develop DKD in the CD1 uninephrectomized streptozotocin mouse model","volume":"13","author":"Trink","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejim.2026.107222_bib0041","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 Inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.ejim.2026.107222_bib0042","first-page":"1491","article-title":"The gut microbiota and diabetes: research, translation, and clinical applications-2023 diabetes, diabetes care, and Diabetologia expert forum","volume":"47","author":"Byndloss","year":"2024","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ejim.2026.107222_bib0043","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod Mikhail","year":"2023","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.ejim.2026.107222_bib0044","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194748","article-title":"GLP-1 and the cardiovascular system","volume":"136","author":"Kahles","year":"2026","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.ejim.2026.107222_bib0046","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.125.325602","article-title":"Cardiovascular, kidney, liver, and metabolic interactions in heart failure: breaking down silos","volume":"136","author":"Lee","year":"2025","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ejim.2026.107222_bib0047","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"issue":"4s","key":"10.1016\/j.ejim.2026.107222_bib0048","first-page":"S117","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ejim.2026.107222_bib0049","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ejim.2026.107222_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007264","article-title":"Cardio-renal-metabolic care models: toward achieving effective interdisciplinary care","volume":"13","author":"Rangaswami","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.ejim.2026.107222_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108101","article-title":"DCRM multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases","volume":"36","author":"Handelsman","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ejim.2026.107222_bib0052","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag098","article-title":"2026 ESC guidelines for the management of cardiovascular disease and chronic kidney disease","author":"Damman","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107222_bib0053","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag100","article-title":"2026 ESC guidelines for the management of heart failure","author":"K\u00f8ber","year":"2026","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ejim.2026.107222_bib0054","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.3390\/jcm14248930","article-title":"Evaluation, management and therapeutic approach of cardiovascular-kidney-metabolic syndrome: a multidisciplinary Delphi expert consensus","volume":"14","author":"Orozco-Beltr\u00e1n","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.107222_bib0055","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.88.5.2277","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction: SOLVD (Studies of Left Ventricular Dysfunction) investigators","volume":"88","author":"Konstam","year":"1993","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ejim.2026.107222_bib0056","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"329","author":"Pagidipati","year":"2023","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ejim.2026.107222_bib0057","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3390\/nu14163391","article-title":"Impact of a multidisciplinary approach on cardiometabolic risk reduction in a multiracial cohort of adults: a 1-year pilot study","volume":"14","author":"Nieto-Mart\u00ednez","year":"2022","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.ejim.2026.107222_bib0058","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.107222_bib0059","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"23","key":"10.1016\/j.ejim.2026.107222_bib0060","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2026.107222_bib0061","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ejim.2026.107222_bib0062","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.107222_bib0063","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.119.042685","article-title":"Heart failure risk stratification and efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus","volume":"140","author":"Berg","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.107222_bib0064","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107222_bib0065","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2026.107222_bib0066","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0067","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2026.107222_bib0068","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ypmed.2014.02.001","article-title":"Perceived judgment about weight can negatively influence weight loss: a cross-sectional study of overweight and obese patients","volume":"62","author":"Gudzune","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/j.ejim.2026.107222_bib0069","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/oby.23154","article-title":"Weight can't wait: a guide to discussing obesity and organizing treatment in the primary care setting","volume":"29","author":"Gallagher","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.ejim.2026.107222_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"20","key":"10.1016\/j.ejim.2026.107222_bib0071","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejim.2026.107222_bib0072","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"issue":"9784","key":"10.1016\/j.ejim.2026.107222_bib0073","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.107222_bib0074","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study: SAVE investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.107222_bib0075","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejim.2026.107222_bib0076","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.hlc.2025.05.095","article-title":"Implementation barriers to evidence-based cardiovascular-kidney-metabolic syndrome management","volume":"34","author":"Davis","year":"2025","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0077","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.126.080672","article-title":"Beyond siloed care: the promise and challenge of cardiovascular-kidney-metabolic syndrome","volume":"154","author":"Berg","year":"2026","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ejim.2026.107222_bib0078","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036518","article-title":"Integrating social determinants of health in the management of cardiovascular-kidney-metabolic syndrome","volume":"13","author":"April-Sanders","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejim.2026.107222_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100564","article-title":"Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among medicare-insured adults with CKD in the United States","volume":"5","author":"Zhao","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.ejim.2026.107222_bib0080","article-title":"Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes \u2013 a Danish nationwide observational study","volume":"14","author":"Falkentoft","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ejim.2026.107222_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102426","article-title":"Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study","volume":"68","author":"Forbes","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejim.2026.107222_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102299","article-title":"Total-body positron emission tomography: investigating mechanisms in cardiovascular-kidney-metabolic syndrome","volume":"51","author":"Brown","year":"2025","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2026.107222_bib0083","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/jcm14124305","article-title":"Renal fat accumulation assessed by MRI or CT and its association with clinical and metabolic disorders: a systematic imaging review","volume":"14","author":"Raphael","year":"2025","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ejim.2026.107222_bib0084","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cmet.2024.02.002","article-title":"Transforming the cardiometabolic disease landscape: multimodal AI-powered approaches in prevention and management","volume":"36","author":"Muse","year":"2024","journal-title":"Cell Metab"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:40:58Z","timestamp":1791326458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526005273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":84,"alternative-id":["S0953620526005273"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107222","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative holistic treatment for CKM: what lies ahead?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"107222"}}